Spironolactone Tablet, Film Coated
Product Images NDC 70518-4468

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-4468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
This text provides information on a study comparing Spironolactone to a Placebo involving 822 and 841 participants, respectively. The Log-rank p-value was found to be less than 0.001, indicating statistical significance. The timeline of the study was tracked from 0 to 42 months.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
This text appears to be a data table related to a study or research on heart failure patients. It includes information such as subgroup specifications, age, sex, race, left ventricular ejection fraction, heart failure indicators, diabetes, serum creatinine levels, potassium levels, and treatment details like the use of Digoxin, ACE inhibitors, and Beta Blockers. The data also appears to show levels for heart rate and 95% confidence intervals for different parameters. Additionally, the text mentions the comparison between Spironolactone and Placebo in the treatment outcomes.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a medication label for Spironolactone tablets. The tablets are manufactured by Zydus Pharm in Pennington, NJ. Each tablet contains 50 mg of Spironolactone. It should be stored at room temperature away from light and children. The usual dosage instructions are provided in the insert. The medication is repackaged by RemedyRepack Inc. located in Indiana, PA.*
FDA Label Image

Mm2 (Spironolactone 50mg 70518 4468 01)

Mm2 (Spironolactone 50mg 70518 4468 01)
This text provides details about a medication called Spironolactone Tablet, manufactured by Zydus Pharmaceuticals. The medication should be protected from light and kept out of reach of children. It should be stored at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). The usual dosage information is on the insert. Additional information includes NDC numbers, lot numbers, expiration date, and details about repackaging by RemedyRepack Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.